Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Organizational Evolution: Balancing Exploration & Development

Posted on April 26th, 2017 by

Rubius Therapeutics had an extraordinary 2016. We were able to dramatically progress our work on the technology platform (where we expanded the number of different ways that we can express proteins) Continue reading “Organizational Evolution: Balancing Exploration & Development” »

Assessing Our Progress and Looking Ahead

Posted on April 21st, 2017 by

Like many start-ups, Reset Therapeutics has been driven by big ideas, which we have pursued with passion, commitment and accountability. Continue reading “Assessing Our Progress and Looking Ahead” »

Reaxys: Increasing Efficiency in the Lab

Posted on April 19th, 2017 by

Bruce Clapham is Director and Head of Medicinal Chemistry at the San Francisco-based Reset Therapeutics, a start-up dedicated to using the body’s natural circadian system to discover and develop new therapies. “My job is to run the chemistry lab and to be a leader in the design of new molecules Continue reading “Reaxys: Increasing Efficiency in the Lab” »

Adding Talent to the Reset Team

Posted on April 7th, 2017 by

Last year was a significant growth year for Reset Therapeutics, in terms of our work and with our team doubling in size. Reset’s success has been due to a strict focus on our proprietary knowledge of how to modify circadian rhythms in cells, tissues and animals using novel small molecules.  Continue reading “Adding Talent to the Reset Team” »

  1. 1
  2. 2
  3. 3
  4. 5